290 related articles for article (PubMed ID: 12137679)
21. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Conwell LS; Chang AB
Cochrane Database Syst Rev; 2009 Oct; (4):CD002010. PubMed ID: 19821288
[TBL] [Abstract][Full Text] [Related]
22. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.
Berenson JR; Hillner BE; Kyle RA; Anderson K; Lipton A; Yee GC; Biermann JS;
J Clin Oncol; 2002 Sep; 20(17):3719-36. PubMed ID: 12202673
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
24. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonates and breast carcinoma.
Lipton A
Cancer; 1997 Oct; 80(8 Suppl):1668-73. PubMed ID: 9362434
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R; Golmohammadi K; Johnston RV; Owen RJ; Homik J; Jones A; Dhillon SS; Kallmes DF; Lambert RG
Cochrane Database Syst Rev; 2015 Apr; (4):CD006349. PubMed ID: 25923524
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumour activity of bisphosphonates in human myeloma cells.
Shipman CM; Rogers MJ; Apperley JF; Graham R; Russell G; Croucher PI
Leuk Lymphoma; 1998 Dec; 32(1-2):129-38. PubMed ID: 10037008
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
Berenson JR; Lichtenstein A; Porter L; Dimopoulos MA; Bordoni R; George S; Lipton A; Keller A; Ballester O; Kovacs MJ; Blacklock HA; Bell R; Simeone J; Reitsma DJ; Heffernan M; Seaman J; Knight RD
N Engl J Med; 1996 Feb; 334(8):488-93. PubMed ID: 8559201
[TBL] [Abstract][Full Text] [Related]
29. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
[TBL] [Abstract][Full Text] [Related]
30. Conservative interventions for treating middle third clavicle fractures in adolescents and adults.
Lenza M; Faloppa F
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD007121. PubMed ID: 27977849
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound and shockwave therapy for acute fractures in adults.
Griffin XL; Smith N; Parsons N; Costa ML
Cochrane Database Syst Rev; 2012 Feb; (2):CD008579. PubMed ID: 22336847
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonates in multiple myeloma.
Berenson JR
Cancer; 1997 Oct; 80(8 Suppl):1661-7. PubMed ID: 9362433
[TBL] [Abstract][Full Text] [Related]
33. Surgical interventions for treating acute fractures or non-union of the middle third of the clavicle.
Lenza M; Faloppa F
Cochrane Database Syst Rev; 2015 May; 2015(5):CD007428. PubMed ID: 25950424
[TBL] [Abstract][Full Text] [Related]
34. Interventions for preventing bone disease in kidney transplant recipients.
Palmer S; McGregor DO; Strippoli GF
Cochrane Database Syst Rev; 2005 Apr; (2):CD005015. PubMed ID: 15846740
[TBL] [Abstract][Full Text] [Related]
35. Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.
Brincker H; Westin J; Abildgaard N; Gimsing P; Turesson I; Hedenus M; Ford J; Kandra A
Br J Haematol; 1998 May; 101(2):280-6. PubMed ID: 9609523
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Kraj M; Pogłód R; Maj S; Pawlikowski J; Sokołowska U; Szczepanik J
Acta Pol Pharm; 2002; 59(6):478-82. PubMed ID: 12669777
[TBL] [Abstract][Full Text] [Related]
37. Bisphosphonate therapy in multiple myeloma.
Laakso M; Jantunen E
Acta Oncol; 1996; 35 Suppl 5():55-6. PubMed ID: 9142966
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonates in multiple myeloma.
Apperley JF; Croucher PI
Pathol Biol (Paris); 1999 Feb; 47(2):178-81. PubMed ID: 10192885
[TBL] [Abstract][Full Text] [Related]
39. Treatment of painful bone lesions and hypercalcemia.
Ascari E; Attardo-Parrinello G; Merlini G
Eur J Haematol Suppl; 1989; 51():135-9. PubMed ID: 2534078
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
